Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.

Saphner T, Troxel AB, Tormey DC, Neuberg D, Robert NJ, Pandya KJ, Edmonson JH, Rosenbluth RJ, Abeloff MD.

J Clin Oncol. 1993 Aug;11(8):1529-35.

PMID:
8336191
2.
3.

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

Carlson RW, Henderson IC.

Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. Review.

PMID:
14535531
4.

Gn-RH agonists in breast and gynaecologic cancer treatment.

Nicholson RI, Walker KJ.

J Steroid Biochem. 1989 Oct;33(4B):801-4. Review.

PMID:
2532269
5.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
6.

Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.

Jankowitz RC, McGuire KP, Davidson NE.

Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032. Review.

PMID:
24074781
7.

Recent perspectives of endocrine therapy for breast cancer.

Utsumi T, Kobayashi N, Hanada H.

Breast Cancer. 2007;14(2):194-9. Review.

8.

Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.

Jonat W.

Br J Cancer. 2001 Nov;85 Suppl 2:1-5. Review. Erratum in: Br J Cancer 2002 Dec 2;87(12):1480.

9.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
11.

A vision for the future?

Baum M.

Br J Cancer. 2001 Nov;85 Suppl 2:15-8. Review.

12.

Overview of luteinizing hormone-releasing hormone agonists in early breast cancer-benefits of reversible ovarian ablation.

Jonat W.

Breast Cancer Res Treat. 2002 Oct;75 Suppl 1:S23-6: discussion S33-5. Review.

PMID:
12353820
13.

Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

Tan SH, Wolff AC.

Clin Breast Cancer. 2007 Feb;7(6):455-64. Review.

PMID:
17386122

Supplemental Content

Support Center